Volume 12, Issue 8, Pages (August 2013)

Slides:

Advertisements

Similar presentations

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants The Lancet Volume 387, Issue 10027,

Advertisements

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta- analysis of the randomised trials The Lancet Volume 386, Issue 10001,

Volume 370, Issue 9586, Pages (August 2007)

Volume 386, Issue 9988, Pages (July 2015)

Volume 12, Issue 11, Pages (October 2011)

Volume 383, Issue 9928, Pages (May 2014)

Volume 385, Issue 9985, Pages (June 2015)

Individual gene expression and personalised medicine in sepsis

Volume 388, Issue 10058, Pages (November 2016)

Volume 58, Issue 2, Pages (August 2010)

Volume 386, Issue 9992, Pages (August 2015)

Volume 388, Issue 10042, Pages (July 2016)

Volume 376, Issue 9734, Pages (July 2010)

Volume 17, Issue 2, Pages (February 2016)

Volume 384, Issue 9958, Pages (November 2014)

Volume 11, Issue 6, Pages (June 2012)

Volume 384, Issue 9958, Pages (November 2014)

Volume 384, Issue 9952, Pages (October 2014)

Volume 376, Issue 9734, Pages (July 2010)

Statins and type 2 diabetes: genetic studies on target

Volume 14, Issue 5, Pages (May 2015)

Volume 16, Issue 8, Pages (August 2015)

John R. Meuleman, MD, William F. Brechue, PhD, Paul S

Volume 385, Issue 9967, Pages (February 2015)

Volume 382, Issue 9891, Pages (August 2013)

Volume 14, Issue 4, Pages (April 2015)

Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study Matthew Waxman, MD,

A Randomized, Double-Blind, Placebo-Controlled Trial of Nutritional Supplementation During Acute Illness Salah Gariballa, MD, Sarah Forster, MSc, Stephen.

Aspirin in the prevention of cancer – Author's reply

ECASS-II: intravenous alteplase in acute ischaemic stroke

Volume 13, Issue 4, Pages (April 2014)

Volume 379, Issue 9834, Pages (June 2012)

Volume 9, Issue 9, Pages (September 2010)

Volume 386, Issue 10001, Pages (October 2015)

Volume 379, Issue 9812, Pages (January 2012)

Volume 14, Issue 5, Pages (May 2015)

Volume 386, Issue 10001, Pages (October 2015)

Volume 14, Issue 9, Pages (September 2015)

Volume 386, Issue 9992, Pages (August 2015)

Volume 382, Issue 9890, Pages (August 2013)

Volume 385, Issue 9985, Pages (June 2015)

Volume 7, Issue 11, (November 2010)

Volume 388, Issue 10058, Pages (November 2016)

Volume 379, Issue 9834, Pages (June 2012)

Volume 388, Issue 10042, Pages (July 2016)

Volume 371, Issue 9627, Pages (May 2008)

Volume 2, Issue 5, Pages (May 2015)

Volume 385, Issue 9968, Pages (February 2015)

Volume 16, Issue 8, Pages (August 2015)

Volume 383, Issue 9928, Pages (May 2014)

Volume 373, Issue 9658, Pages (January 2009)

Volume 375, Issue 9719, Pages (March 2010)

Volume 15, Issue 1, Pages (January 2014)

Volume 13, Issue 12, Pages (December 2014)

Thank you to our diverse (but not diverse enough) reviewers

ACST: which subgroups will benefit most from carotid endarterectomy?

Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study Sarah.

Volume 2, Issue 10, Pages (October 2015)

Artefenomel: a promising new antimalarial drug

Volume 14, Issue 9, Pages (September 2015)

Volume 13, Issue 7, Pages (July 2014)

Interferon alfa-2a for melanoma metastases

Stephen P. Mcdonald, Graeme R. Russ Kidney International

ECASS-II: intravenous alteplase in acute ischaemic stroke

Volume 388, Issue 10042, Pages (July 2016)

Volume 64, Issue 4, Pages (October 2003)

Kaplan-Meier curves for overall survival in patients with adenocarcinoma and time since first-line therapy of

Pleurodesis for primary spontaneous pneumothorax – Authors' reply

Volume 17, Issue 2, Pages (February 2016)

Presentation transcript:

Volume 12, Issue 8, Pages 768-776 (August 2013) Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial The Lancet Neurology Volume 12, Issue 8, Pages 768-776 (August 2013) DOI: 10.1016/S1474-4422(13)70130-3 Copyright © 2013 The IST-3 collaborative group. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 1 Trial profile EQ=EuroQoL. *Of the patients who were known to be alive at 18 months, 24 in the alteplase group versus 27 in the control group had a known date of death more than 18 months after enrolment, but their disability status at 18 months was unknown. The Lancet Neurology 2013 12, 768-776DOI: (10.1016/S1474-4422(13)70130-3) Copyright © 2013 The IST-3 collaborative group. Open Access article distributed under the terms of CC BY Terms and Conditions

Figure 2 Kaplan-Meier survival curves The Lancet Neurology 2013 12, 768-776DOI: (10.1016/S1474-4422(13)70130-3) Copyright © 2013 The IST-3 collaborative group. Open Access article distributed under the terms of CC BY Terms and Conditions